期刊文献+

胃癌病理分子学中相关肿瘤标志物的研究新进展

下载PDF
导出
摘要 胃癌疾病相应进展过程当中涉及到多种癌基因抗癌基因,是属于多途径协同作用产物,因此,在疾病早期发现基因标志物与胃癌疾病发生、发展以及预后有一定联系.对于胃癌疾病诊断大多采用胃镜、病理、X线等技术,但是此三种检测技术会对患者造成一定创伤,影响其身心健康.近些年来,随着我国检测技术不断发展,通过血清、其他液体监测肿瘤标志物应用效果明显,能够作为疾病辅助诊断.本文就胃癌病理分子学中相关肿瘤标志物研究新进展进行探究,具体如下.
作者 卢运龙
出处 《医学食疗与健康》 2018年第5期198-199,共2页 Medical Diet and Health
  • 相关文献

参考文献18

二级参考文献110

  • 1Xin Jiao,Hong-Jun Lu,Mi-Mi Zhai,Zhi-Jun Tan,Hai-Ning Zhi,Xiao-Man Liu,Chen-Hao Liu,Da-Peng Zhang.Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer[J].World Journal of Gastroenterology,2013,19(48):9425-9431. 被引量:7
  • 2陈智伟,廖美琳.RECIST标准在肿瘤治疗疗效评价中的应用[J].中国肿瘤,2004,13(10):616-618. 被引量:174
  • 3王阳,楮福楼.血清肿瘤标志物CEA、CA19-9联合检测在胃癌患者术后中的临床应用[J].中国实验诊断学,2007,11(6):818-819. 被引量:5
  • 4李烜,胡守友.胃癌患者血清CEA、CA724、CA242、VEGF联合测定的临床意义[J].中国血液流变学杂志,2007,17(3):453-455. 被引量:21
  • 5Bones J, Byrne JC, Odonoghue N, et al. Glycomic and glycopro- teomie analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms [ J 1. Journal of Proteome Research,2011,29 ( 3 ) :649 - 651.
  • 6Jun Chu, 1 ParkJae-Hoon Lee, Kungseok Cheoi, et al. Predictive val- ue of pretreatment metabolic activity measured by fluorodeoxyglucose positron emission tomography in patients with metastatic advanced gastric cancer: the maximal SUV of the stomach is a prognostic fac- tor[J]. European Journal of Nuclear Medicine and Molecular Ima- ging,2012,31 (7) :291 -296.
  • 7Zhang S, Zuo Li, Gui S, et al. Induction of cell differentiation andpromotion of endocan gene expression in stomach cancer by melato- nin [ J ]. Mol Biol Rep ,2012,39 ( 3 ) :2843 - 2849.
  • 8Gunassekaran GR,Priya DK, Gayathri R,et al. In vitro and in vivo studies on antitumor effects of gossypol on human stomach adenocar- cinoma (AGS) cell line and MNNG induced experimental gastric cancer[ J ]. Biochemical and Biophysical Research Communica- tions,2011,26(4) :618 -621.
  • 9Ukaszewicz-Zajac M,Mroczko B,Kozlowski M,et al.Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma[J].Pol Arch Med Wewn,2009,119(9):558-563.
  • 10Mehta J,Prabhu R,Eshpunigani P,et al.Evaluating the efficacy of tumor markers CA19-9 and CEA to predict operability and survival in pancreatic malignancies[J].Trop Gastroenterol,2010,31(3):190-194.

共引文献305

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部